IceCure Medical (ICCM) Share-based Compensation (2020 - 2026)
IceCure Medical's (ICCM) quarterly Share-based Compensation came in at $180000.0 in Q1 2026, up 44.0% year-on-year from $125000.0 in Q1 2025, and down 33.58% on a QoQ basis from $271000.0 in Q4 2025.
IceCure Medical (ICCM) Share-based Compensation (2020 - 2026) Analysis & Trends
IceCure Medical (ICCM) has 7 years of Share-based Compensation data on file, last reported at $180000.0 in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 44.0% year-over-year to $180000.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 84.26% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 55.32% from the prior year.
- Share-based Compensation for Q1 2026 stood at $180000.0, down from $271000.0 in the prior quarter.
- Over the last five years, Share-based Compensation for ICCM reached as high as $884000.0 in Q4 2024 and fell as low as -$814000.0 in Q4 2023.
- Historically, Share-based Compensation has averaged $294375.0 across 5 years, with a median of $294500.0 in 2023.
- Across the five-year window, Share-based Compensation soared 725.81% in 2022 and plunged 258.98% in 2023, its largest moves.
- Year by year, Share-based Compensation stood at $512000.0 in 2022, then plunged by 258.98% to -$814000.0 in 2023, then surged by 208.6% to $884000.0 in 2024, then plunged by 69.34% to $271000.0 in 2025, then slumped by 33.58% to $180000.0 in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $180000.0 in Q1 2026, $271000.0 in Q4 2025, and $807000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 176.38 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 108.84 Bn | 99.62 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 48.68 Bn | 45.01 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 35.80 Mn |
| 7 | GE HealthCare Technologies | 28.38 Bn | 26.09 Bn | 1.98 Bn | 35.00 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.50 Bn | 22.38 Bn | 2.07 Bn | 35.12 Mn |
| 10 | IceCure Medical | 7.31 Mn | -806,722.79 | 295,000.00 | 180,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180,000.00 |
| Mar 31, 2026 | 180,000.00 |
| Dec 31, 2025 | 271,000.00 |
| Dec 31, 2025 | 271,000.00 |
| Sep 30, 2025 | 807,000.00 |
| Sep 30, 2025 | 807,000.00 |
| Jun 30, 2025 | 170,000.00 |
| Jun 30, 2025 | 170,000.00 |
| Mar 31, 2025 | 125,000.00 |
| Mar 31, 2025 | 125,000.00 |
| Dec 31, 2024 | 884,000.00 |
| Dec 31, 2024 | 884,000.00 |
| Sep 30, 2024 | 240,000.00 |
| Sep 30, 2024 | 240,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Jun 30, 2024 | 165,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Mar 31, 2024 | 245,000.00 |
| Dec 31, 2023 | -814,000.00 |
| Dec 31, 2023 | -814,000.00 |